BioNTech SE (BNTX)
BioNTech to Host Innovation Series R&D Day on November 11, 2025
Accuray Incorporated (ARAY)
Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025
Alto Neuroscience Inc. (ANRO)
Alto Neuroscience to Participate in Upcoming Investor Conferences
Cronos Group Inc (CRON)
Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season
Kiniksa Pharmaceuticals (KNSA)
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
Context Therapeutics Inc. (CNTX)
Context Therapeutics to Participate in Upcoming Investor Conferences
TG Therapeutics Inc. (TGTX)
TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI
Repligen Corporation (RGEN)
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
Unicycive Therapeutics Inc. (UNCY)
Unicycive Therapeutics Provides Update from FDA Type A Meeting and Expects to Resubmit OLC NDA Before Year-End
NeoGenomics Inc (NEO)
NeoGenomics Reports Third Quarter 2025 Results